5 Best Low Risk Stocks To Buy In 2022

3. UnitedHealth Group Incorporated (NYSE:UNH)

Number of Hedge Fund Holders: 91

Beta Value: 0.75

UnitedHealth Group Incorporated (NYSE:UNH) operates as a diversified healthcare company in the United States. It operates through four segments – UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. On October 14, the company reported Q3 non-GAAP earnings per share of $5.79 and a revenue of $80.9 billion, topping market estimates by $0.35 and $360 million, respectively. The company raised its full year 2022 net earnings outlook to $20.85-$21.05 per share and adjusted net earnings to $21.85-$22.05 per share, compared to a consensus of $21.89 and prior view of $21.4-$21.9.

On October 18, Deutsche Bank analyst George Hill raised the price target on UnitedHealth Group Incorporated (NYSE:UNH) to $615 from $569 and reiterated a Buy rating on the shares. The company announced strong Q3 results on the back of robust membership growth and expanding value-based arrangements, the analyst told investors in a research note.

According to Insider Monkey’s Q2 data, UnitedHealth Group Incorporated (NYSE:UNH) was part of 91 hedge fund portfolios, compared to 103 funds in the earlier quarter. Boykin Curry’s Eagle Capital Management is a prominent stakeholder of the company, with 2.8 million shares worth $1.5 billion. 

Here is what Carillon Tower Advisers specifically said about UnitedHealth Group Incorporated (NYSE:UNH) in its Q2 2022 investor letter:

“UnitedHealth Group Incorporated (NYSE:UNH) reported solid quarterly results and raised 2022 guidance modestly. Additionally, managed care is another industry that is viewed as defensive in the current environment, which helped support UnitedHealth and its peer group.”